Boule Diagnostics AB (publ) (STO:BOUL)

Market Cap	309.38M
Revenue (ttm)	558.50M
Net Income (ttm)	-223.30M
Shares Out	38.83M
EPS (ttm)	-5.75
PE Ratio	n/a
Forward PE	13.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	510
Average Volume	37,124
Open	7.86
Previous Close	7.72
Day's Range	7.86 - 8.00
52-Week Range	6.50 - 11.50
Beta	0.41
RSI	34.00
Earnings Date	Apr 11, 2025

About Boule Diagnostics AB

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1956
• Employees: 200
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BOUL